LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,189,000 | +6.7% | 30,068 | +0.5% | 0.01% | 0.0% |
| Q2 2021 | $3,925,000 | -10.7% | 29,921 | +3.8% | 0.01% | -16.7% |
| Q1 2021 | $4,395,000 | -34.7% | 28,826 | -57.4% | 0.01% | -33.3% |
| Q4 2020 | $6,727,000 | +81.9% | 67,644 | +74.3% | 0.02% | +38.5% |
| Q3 2020 | $3,699,000 | -9.1% | 38,807 | +6.7% | 0.01% | -18.8% |
| Q2 2020 | $4,069,000 | +67.4% | 36,383 | +8.8% | 0.02% | +23.1% |
| Q1 2020 | $2,431,000 | -2.3% | 33,426 | +40.2% | 0.01% | 0.0% |
| Q4 2019 | $2,487,000 | +328.8% | 23,847 | +309.0% | 0.01% | +333.3% |
| Q3 2019 | $580,000 | -12.9% | 5,831 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $666,000 | +85.5% | 5,831 | +104.3% | 0.00% | +100.0% |
| Q1 2019 | $359,000 | – | 2,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |